Clinical-stage biotechnology company Lineage Cell Therapeutics has named George A. Samuel III as general counsel and corporate secretary.
Samuel will lead the company’s legal operations, bringing extensive corporate, transactional, intellectual property, and commercial expertise. Prior to joining Lineage, he most recently served as director, senior counsel for Lytx, where he managed the commercial legal operations for an international video telematics SaaS company.
Prior to that, Samuel worked as VP, general counsel and corporate secretary for Cardiff Oncology (formerly known as Trovagene). Samuel also practiced corporate law at major law firms, including DLA Piper and Cooley.